OR2AS2P

Across TCGA pan-cancer cohorts, OR2AS2P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated OR2AS2P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher OR2AS2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR2AS2P expression acts as an unfavorable survival marker.

OV, LIHC, and PRAD are the cancer types where OR2AS2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.286	0.542	.040	54	view →
LIHC	DFS	Tertile	II,III,IV	0.067	0.429	<.001	45	view →
PRAD	OS	Tertile	All	0.967	0.995	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OR2AS2P–OV (DFS)

Open the OV breakdown →